Themes: Inflammation

The Centenary Institute has celebrated the publication of a new book, 'The Good Gut Anti-Inflammatory Diet’ at a special event, held at the Dymocks Bookstore, Sydney.

A breakthrough discovery in understanding how white blood cells move in the body could pave the way for new treatments for chronic inflammation-related diseases including cardiovascular diseases, according to a recent study from the Centenary Institute.

A new study led by the Centenary Institute and the University of Bonn has revealed new insights into the early stages of chronic obstructive pulmonary disease (COPD), a debilitating respiratory condition characterised by inflammation in the lungs and severe breathing difficulties.

Professor Phil Hansbro, Director of the Centenary UTS Centre for Inflammation, has been interviewed on the Good Reading podcast about his recently published book, ‘The Good Gut Anti-Inflammatory Diet’.

Researchers, including Dr Matt Johansen from the Centenary UTS Centre for Inflammation and Professor Phil Hansbro, Director of the Centenary UTS Centre for Inflammation, have discovered that a cancer drug could play an important role in limiting the damaging effects of lung disease in COVID-19 patients.

The Centenary UTS Centre for Inflammation has hosted the 17th Annual National Airways Meeting (NAMe) held at the Centenary Institute, 26-27 October 2023.

Researchers have revealed that the protein Toll-like receptor 7 (TLR7), usually associated with antiviral defence in the body, surprisingly, exacerbates lung conditions such as chronic obstructive pulmonary disease (COPD), also known as emphysema.

Research led by the Centenary Institute, the University of Technology Sydney and the Hunter Medical Research Institute suggests that the gut microbiome plays a pivotal role in the development of chronic obstructive pulmonary disease (COPD), paving the way for new therapeutic treatments.